Advanced Enzyme Q1 FY27 Earnings Call — Analysis (NSE: ADVENZYMES)
Soft Q1 with 2% YoY revenue growth and margin compression, but management reaffirms double-digit FY27 growth and announces ₹69.7 Cr buyback.
Result quality: stable — Steady quarter. Management sentiment: neutral.
The take
Q1FY27 Revenue ₹189.8 Cr ( +2% YoY ) .
Results
Revenue ₹189.8 Cr (+2% YoY), EBITDA margin 27% (-300bps YoY), PAT ₹38.6 Cr (-5% YoY); an incremental sales reversal of ₹10 Cr impacted the quarter.
Financial highlights
| Metric | Value | Change | Basis |
|---|---|---|---|
| Revenue | ₹189.8 Cr | +2% | yoy · Q1FY27 · vs Q1FY26 |
| Revenue | ₹189.8 Cr | -7% | qoq · Q1FY27 · vs Q4FY26 |
| EBITDA | ₹51.0 Cr | -10% | yoy · Q1FY27 · vs Q1FY26 |
| EBITDA | ₹51.0 Cr | -19% | qoq · Q1FY27 · vs Q4FY26 |
| EBITDA Margin | 27% | -300bps | yoy · Q1FY27 · vs Q1FY26 |
| PAT | ₹38.6 Cr | Q1FY27 |
Guidance
FY27 double-digit revenue growth and consolidated EBITDA margin recovery to ~30%.
Key themes
Muted Q1, buyback, and recovery confidence.
Research and educational content only. Not investment advice.